Flandez M, Guilmeau S, Blache P, Augenlicht L H
Department of Oncology, Albert Einstein Cancer Center, Montefiore Medical Center, 111 East 210th St. Bronx, NY 10467, USA.
Exp Cell Res. 2008 Dec 10;314(20):3712-23. doi: 10.1016/j.yexcr.2008.10.004. Epub 2008 Oct 21.
The Krüppel-like factor 4 (KLF4) transcription factor suppresses tumorigenesis in gastrointestinal epithelium. Thus, its expression is decreased in gastric and colon cancers. Moreover, KLF4 regulates both differentiation and growth that is likely fundamental to its tumor suppressor activity. We dissected the expression of Klf4 in the normal mouse intestinal epithelium along the crypt-villus and cephalo-caudal axes. Klf4 reached its highest level in differentiated cells of the villus, with levels in the duodenum>jejunum>ileum, in inverse relation to the representation of goblet cells in these regions, the lineage previously linked to KLF4. In parallel, in vitro studies using HT29cl.16E and Caco2 colon cancer cell lines clarified that KLF4 increased coincident with differentiation along both the goblet and absorptive cell lineages, respectively, and that KLF4 levels also increased during differentiation induced by the short chain fatty acid butyrate, independently of cell fate. Moreover, we determined that lower levels of KLF4 expression in the proliferative compartment of the intestinal epithelium are regulated by the transcription factors TCF4 and SOX9, an effector and a target, respectively, of beta-catenin/Tcf signaling, and independently of CDX2. Thus, reduced levels of KLF4 tumor suppressor activity in colon tumors may be driven by elevated beta-catenin/Tcf signaling.
Krüppel样因子4(KLF4)转录因子可抑制胃肠道上皮细胞的肿瘤发生。因此,其在胃癌和结肠癌中的表达降低。此外,KLF4调节分化和生长,这可能是其肿瘤抑制活性的基础。我们剖析了正常小鼠肠道上皮中Klf4沿隐窝-绒毛轴和头-尾轴的表达情况。Klf4在绒毛的分化细胞中达到最高水平,十二指肠>空肠>回肠中的水平与这些区域杯状细胞的数量呈反比,杯状细胞是先前与KLF4相关的谱系。同时,使用HT29cl.16E和Caco2结肠癌细胞系进行的体外研究表明,KLF4分别与杯状细胞和吸收性细胞谱系的分化同时增加,并且在短链脂肪酸丁酸盐诱导的分化过程中,KLF4水平也会增加,与细胞命运无关。此外,我们确定肠道上皮增殖区中较低水平的KLF4表达受转录因子TCF4和SOX9调控,它们分别是β-连环蛋白/Tcf信号通路的效应器和靶点,且与CDX2无关。因此,结肠肿瘤中KLF4肿瘤抑制活性的降低可能是由β-连环蛋白/Tcf信号通路的升高驱动的。